Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) traded up 7.6% during mid-day trading on Wednesday . The company traded as high as $1.70 and last traded at $1.70. 200 shares were traded during mid-day trading, a decline of 98% from the average session volume of 11,481 shares. The stock had previously closed at $1.58.
Nutriband Price Performance
The stock’s 50 day simple moving average is $1.68 and its 200-day simple moving average is $1.78.
Hedge Funds Weigh In On Nutriband
A hedge fund recently raised its stake in Nutriband stock. Citadel Advisors LLC grew its position in Nutriband Inc. (NASDAQ:NTRBW – Free Report) by 8.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 126,392 shares of the company’s stock after purchasing an additional 9,801 shares during the quarter. Citadel Advisors LLC’s holdings in Nutriband were worth $190,000 as of its most recent SEC filing.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
See Also
- Five stocks we like better than Nutriband
- 3 Best Fintech Stocks for a Portfolio Boost
- $30B AI Opportunity: Will It Power Meta’s Next Surge?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Microsoft Could Rally as EU Antitrust Case Nears Resolution
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
